SIX$ALC
Alcon Inc. · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Headline financials
Revenue & EPS history
Alcon · Revenue · Quarterly
CHF 2.16B
Q4 2022+1%vs Q4 2021
Revenue by segment
Alcon · CHF 5.12B total across 6 segments · Q1 2026
- SurgicalCHF 1.46B—28.5%
- Vision CareCHF 1.23B—23.9%
- Surgical — ConsumablesCHF 769M—15.0%
- Vision Care — Contact lensesCHF 738M—14.4%
- Vision Care — Ocular healthCHF 487M—9.5%
- Surgical — ImplantablesCHF 438M—8.6%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2022
+0.7%
Avg return
Earnings day
-1.8%
Avg return
5 days after
-1.5%
Avg return
30 days after
48%
13 / 27 earnings
Positive
+13.0%
Q2 2021
Best reaction
-8.9%
Q2 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | -34.4% | -28.6% | |
| Q3 2025 | +4.6% | -1.0% | +1.9% | |
| Q2 2025 | -8.9% | -10.4% | -14.3% | |
| Q1 2025 | +2.4% | -4.2% | -7.6% | |
| Q3 2024 | -5.2% | -7.7% | -7.1% | |
| Q2 2024 | -1.7% | -0.2% | +2.2% | |
| Q1 2024 | +8.9% | +8.3% | +12.5% | |
| Q4 2023 | +6.4% | +7.7% | +3.4% | |
| Q3 2023 | -2.1% | -2.1% | +7.0% | |
| Q2 2023 | -1.6% | +1.4% | +0.4% | |
| Q1 2023 | +7.6% | +6.0% | +5.4% | |
| Q4 2022 | -3.9% | -3.7% | -4.8% | |
| Q3 2022 | +4.1% | +3.1% | +8.1% | |
| Q2 2022 | -5.4% | -7.9% | -10.4% | |
| Q1 2022 | +8.7% | +10.0% | +12.7% | |
| Q4 2021 | +5.0% | -0.6% | -0.3% | |
| Q3 2021 | -4.2% | -5.9% | -1.4% | |
| Q2 2021 | +13.0% | +13.9% | +21.9% | |
| Q1 2021 | -7.8% | -7.6% | -9.0% | |
| Q4 2020 | -2.1% | -4.4% | -3.1% | |
| Q3 2020 | -1.1% | -0.3% | -1.8% | |
| Q2 2020 | -2.9% | -4.9% | -4.1% | |
| Q1 2020 | +4.3% | +5.0% | +7.0% | |
| Q4 2019 | +4.5% | +1.4% | -20.2% | |
| Q3 2019 | -3.5% | -3.8% | -3.0% | |
| Q2 2019 | -2.0% | -5.1% | -4.1% | |
| Q1 2019 | +2.1% | -0.4% | -3.3% | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — | |
| Q4 2017 | — | — | — | |
| Q4 2011 | — | — | — | |
| Q3 2010 | — | — | — | |
| Q2 2010 | — | — | — | |
| Q1 2009 | — | — | — | |
| Q1 2010 | — | — | — | |
| Q4 2009 | — | — | — | |
| Q4 2007 | — | — | — | |
| Q3 2009 | — | — | — | |
| Q3 2008 | — | — | — | |
| Q4 2008 | — | — | — | |
| Q2 2008 | — | — | — | |
| Q2 2009 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro